ANDREA HARDIN: Open Payments
NPI 1851811145 · COLUMBIA, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,393 in 83 payments from 16 companies in 2025. Trend: 2023 $1,703 · 2024 $1,524 · 2025 $1,393
Food & beverage: $1,383Education: $10
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 22 | $392 |
| ABBVIE INC. | 15 | $190 |
| Janssen Biotech, Inc. | 12 | $182 |
| Lilly USA, LLC | 11 | $156 |
| UCB, Inc. | 3 | $69 |
| E.R. Squibb & Sons, L.L.C. | 4 | $67 |
| LEO Pharma Inc. | 2 | $58 |
| ANI Pharmaceuticals, Inc. | 2 | $50 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $45 |
| Regeneron Healthcare Solutions, Inc. | 2 | $34 |
Products named: COSENTYX, TREMFYA, TALTZ, SKYRIZI, RINVOQ, Bimzelx, Sotyktu, DUPIXENT.
Industry payments across MO — which companies pay providers there.
